[ad_1]
[앵커]
It was revealed that China has administered an experimental vaccine for COVID-19, which has yet to be verified, to hundreds of thousands of people separately from clinical trials. Global health experts are very concerned that China’s action is close to gambling and may lead to false belief. Reporter Park Cheol-won reports. The New York Times reported that China is currently in phase 3 clinical trials and has been vaccinated with an experimental vaccine made in China without testing. The targets of the vaccination were employees of state companies, public officials, and pharmaceutical companies that develop vaccines. The Chinese state pharmaceutical company Sinopharm has revealed that hundreds of thousands of people have been vaccinated. Sinobac Bio Co., Ltd. also announced that it has administered its own vaccine to more than 10,000 people in Beijing alone, and that its 3,000 employees and their families have also received the vaccine. The National Health Commission of the Chinese government held a press conference and showed confidence in the safety of domestic vaccines. At the time of approval for emergency use of the vaccine in July, the Chinese government announced that it would be vaccinated mainly by medical personnel and infectious disease control personnel, but the target was greatly expanded. We plan to use the vaccine for the general public in November after expanding the target for emergency use to schools, kindergarten teachers and employees of large markets in the near future. World health experts worry that China’s shares are close to the game. This is because people who receive untested vaccines can unknowingly pass it on after becoming infected, and can instill the false belief that “I am safe” in those who have been vaccinated. The New York Times also said it would have been difficult for government officials and employees of state or pharmaceutical companies to resist pressure from above to have the vaccine tested. This is YTN Park Cheolwon.
